Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA) in patients with gastric adenocarcinoma.
作者信息
Sordillo P P, Magill G B, Gralla R J, Kelsen D P
出版信息
Am J Clin Oncol. 1982 Jun;5(3):273-5. doi: 10.1097/00000421-198206000-00006.
Abstract
A phase II study of m-AMSA in patients with gastric adenocarcinoma was conducted. Twenty-three patients received m-AMSA, 90-120 mg/m2, every 3 weeks. There were no major responses among 20 evaluable patients, although one patient experienced a minor response. Depression of the white blood count was the most prominent toxicity. m-AMSA has little activity in patients with gastric adenocarcinoma.
摘要
相似文献
1
Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA) in patients with gastric adenocarcinoma.
Am J Clin Oncol. 1982 Jun;5(3):273-5. doi: 10.1097/00000421-198206000-00006.
2
Phase II evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer.4'-(9-吖啶基氨基)甲磺基间茴香胺（AMSA）在非小细胞肺癌患者中的II期评估。
Cancer Treat Rep. 1980 Feb-Mar;64(2-3):345-7.
3
Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma.
Cancer Treat Rep. 1980 Aug-Sep;64(8-9):1009-10.
4
Phase II evaluation of m-AMSA (4'-(9-acridinylamino)-methanesulfon-m-anisidide) in patients with adenocarcinoma of the pancreas.m-AMSA（4'-（9-吖啶基氨基）-甲磺酰间茴香胺）在胰腺癌患者中的II期评估。
Am J Clin Oncol. 1983 Aug;6(4):459-62. doi: 10.1097/00000421-198308000-00011.
5
A phase II evaluation of m-AMSA, 4'-(9-acridinylamino) methanesulfon-m-anisidide, in patients with breast cancer.
Cancer Clin Trials. 1981 Fall;4(3):249-51.
6
Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic hypernephroma.
Cancer Treat Rep. 1980 Jan;64(1):183-5.
7
Phase II trial of (m-AMSA) 4'-9-(acridinylamino)-methanesulfon-m-aniside in primary liver cancer.
Am J Clin Oncol. 1983 Apr;6(2):211-3. doi: 10.1097/00000421-198304000-00013.
8
Phase II. Trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in the treatment of advanced non-Hodgkin's lymphoma.
Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1157-8.
9
Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule.
Cancer Treat Rep. 1980 Jan;64(1):53-5.
10
Phase II trial of amsacrine (m-AMSA) in advanced ovarian carcinoma.氨吖啶（m-AMSA）用于晚期卵巢癌的II期试验。
Eur J Cancer Clin Oncol. 1982 Jan;18(1):71-4. doi: 10.1016/0277-5379(82)90027-x.
Zotero 插件